Sign in

CIK 0001595097

  • Non-accelerated filer
  • Smaller reporting company

Corbus Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464348039
Phone
+1 617-963-0103
Business address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Former names
SAV Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,758,438
in 2 filings, $16K under 10b5-1 plans

Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-07 Moran Sean F. Chief Financial Officer Sale 10b5-1 −12,000 $10.08 $121K 84,694
2026-02-13 Moran Sean F. Chief Financial Officer Sale 10b5-1 −4,701 $7.78 $37K 96,694
2026-01-14 Moran Sean F. Chief Financial Officer Grant or award +28,082 101,395
2026-01-14 Moran Sean F. Chief Financial Officer Grant or award · Stock options (right to buy) +84,247 84,247
2025-10-24 Moran Sean F. Chief Financial Officer Exercise or conversion 10b5-1 +12,981 $4.26 $55K 86,294
2025-10-24 Moran Sean F. Chief Financial Officer Sale 10b5-1 −12,981 $17.02 $221K 73,313
2025-10-24 Moran Sean F. Chief Financial Officer Exercise or conversion · Stock options (right to buy) 10b5-1 −12,981 10,386
2025-02-14 Moran Sean F. Chief Financial Officer Sale 10b5-1 −2,792 $8.76 $24K 73,313
2025-01-31 Moran Sean F. Chief Financial Officer Grant or award +27,500 76,105
2025-01-31 Moran Sean F. Chief Financial Officer Grant or award · Stock options (right to buy) +92,500 92,500
2024-06-18 Moran Sean F. Chief Financial Officer Exercise or conversion 10b5-1 +1,958 $30.00 $59K 50,563
2024-06-18 Moran Sean F. Chief Financial Officer Sale 10b5-1 −1,958 $42.12 $82K 48,605
2024-06-18 Moran Sean F. Chief Financial Officer Exercise or conversion · Options to purchase common stock 10b5-1 −1,958 0
2024-06-17 Moran Sean F. Chief Financial Officer Exercise or conversion 10b5-1 +6,730 $14.10 $95K 55,335
2024-06-17 Moran Sean F. Chief Financial Officer Sale 10b5-1 −6,730 $46.77 $315K 48,605
2024-06-17 Moran Sean F. Chief Financial Officer Exercise or conversion · Options to purchase common stock 10b5-1 −6,730 11,217
2024-06-14 Moran Sean F. Chief Financial Officer Exercise or conversion 10b5-1 +1,567 $30.00 $47K 50,172
2024-06-14 Moran Sean F. Chief Financial Officer Sale 10b5-1 −1,567 $49.87 $78K 48,605
2024-06-14 Moran Sean F. Chief Financial Officer Exercise or conversion 10b5-1 +7,788 $4.26 $33K 56,393
2024-06-14 Moran Sean F. Chief Financial Officer Sale 10b5-1 −7,788 $49.87 $388K 48,605

Page 1 of 3 · 53 trades